{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:55:21Z","timestamp":1792508121068,"version":"4.5.0"},"reference-count":107,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CA A Cancer J Clinicians"],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:p>\n                    The number of cancer survivors continues to increase due to the aging and growth of the population and improvements in early detection and treatment. In order for the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborated to estimate the number of current and future cancer survivors using data from the Surveillance, Epidemiology, and End Results (SEER) program registries. In addition, current treatment patterns for the most common cancer types are described based on information in the National Cancer Data Base and the SEER and SEER\u2010Medicare linked databases; treatment\u2010related side effects are also briefly described. Nearly 14.5 million Americans with a history of cancer were alive on January 1, 2014; by January 1, 2024, that number will increase to nearly 19 million. The 3 most common prevalent cancers among males are prostate cancer (43%), colorectal cancer (9%), and melanoma (8%), and those among females are cancers of the breast (41%), uterine corpus (8%), and colon and rectum (8%). The age distribution of survivors varies substantially by cancer type. For example, the majority of prostate cancer survivors (62%) are aged 70 years or older, whereas less than one\u2010third (32%) of melanoma survivors are in this older age group. It is important for clinicians to understand the unique medical and psychosocial needs of cancer survivors and to proactively assess and manage these issues. There are a growing number of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship.\n                    <jats:bold>CA Cancer J Clin 2014;64:252\u2013271. \u00a9 2014 American Cancer Society.<\/jats:bold>\n                  <\/jats:p>","DOI":"10.3322\/caac.21235","type":"journal-article","created":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T08:19:12Z","timestamp":1401610752000},"page":"252-271","source":"Crossref","is-referenced-by-count":1985,"title":["Cancer treatment and survivorship statistics, 2014"],"prefix":"10.3322","volume":"64","author":[{"given":"Carol E.","family":"DeSantis","sequence":"first","affiliation":[{"name":"Epidemiologist, Surveillance and Health Services Research American Cancer Society Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Chieh","family":"Lin","sequence":"additional","affiliation":[{"name":"Program Manager, Surveillance and Health Services Research American Cancer Society Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela B.","family":"Mariotto","sequence":"additional","affiliation":[{"name":"Chief, Data Modeling Branch, Surveillance Research, Division of Cancer Control and Population Sciences National Cancer Institute Bethesda MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Siegel","sequence":"additional","affiliation":[{"name":"Managing Director, Surveillance and Health Services Research American Cancer Society Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Stein","sequence":"additional","affiliation":[{"name":"Managing Director, Behavioral Research Center American Cancer Society Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan L.","family":"Kramer","sequence":"additional","affiliation":[{"name":"Medical Editor American Cancer Society Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Alteri","sequence":"additional","affiliation":[{"name":"Medical Editor American Cancer Society Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.","family":"Robbins","sequence":"additional","affiliation":[{"name":"Director, Surveillance and Health Services Research American Cancer Society Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmedin","family":"Jemal","sequence":"additional","affiliation":[{"name":"Vice President, Surveillance and Health Services Research American Cancer Society Atlanta GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28509"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-0740"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1304"},{"key":"e_1_2_6_5_1","volume-title":"SEER Cancer Statistics Review, 1975\u20132009","author":"Howlader N","year":"2012"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-006-0072-0"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq495"},{"key":"e_1_2_6_8_1","volume-title":"SEER Cancer Statistics Review, 1975\u20132010","author":"Howlader N","year":"2013"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21208"},{"key":"e_1_2_6_10_1","unstructured":"Surveillance Epidemiology and End Results (SEER) Program.SEER*Stat Database: Incidence\u2010SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases Nov. 2012 Sub (1973\u20132010 varying)\u2010Linked To County Attributes\u2010Total US 1969\u20132011 Counties. Bethesda MD: National Cancer Institute Division of Cancer Control and Population Sciences Surveillance Research Program Surveillance Systems Branch;2013 based on the November 2012 submission."},{"key":"e_1_2_6_11_1","unstructured":"Surveillance Research Program.National Cancer Institute SEER*Stat software. Version 8.1.2. Bethesda MD: Statistical Research and Applications Branch National Cancer Institute;2013."},{"key":"e_1_2_6_12_1","volume-title":"National Cancer Data Base 2011 Data Submission","author":"American College of Surgeons Commission on Cancer","year":"2013"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-2901-1"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.7018"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.2427"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24363"},{"key":"e_1_2_6_17_1","unstructured":"Surveillance Epidemiology and End Results (SEER) Program.SEER\u2010Medicare linked database 2006\u20132010. Bethesda MD: National Cancer Institute Division of Cancer Control and Population Sciences Applied Research Program Health Services and Economics Branch;2013."},{"key":"e_1_2_6_18_1","unstructured":"National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 2.2014; 2014."},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000156922.58631.d7"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0635-x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3181f958de"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.2284"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.02.021"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050518"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2008.1127"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3429"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23131"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70076-7"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20001"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1837"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1568"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604534"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68700-X"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2008.04.001"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr541"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4741.2006.00359.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2011.09.008"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21219"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.6296"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.1920"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.2954"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.053"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22189"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.57.4.242"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2009.07.007"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21220"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.06.010"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-7563.2010.01275.x"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0782"},{"key":"e_1_2_6_50_1","volume-title":"PDQ\u00ae Adult Acute Myeloid Leukemia Treatment","author":"National Cancer Institute","year":"2013"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11664"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-051912"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62187-4"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23078"},{"key":"e_1_2_6_55_1","first-page":"1146","article-title":"Richter's transformation in chronic lymphocytic leukemia","volume":"26","author":"Jain P","year":"2012","journal-title":"Oncology (Williston Park)."},{"key":"e_1_2_6_56_1","unstructured":"Surveillance Epidemiology and End Results (SEER) Program.SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence\u2010CiNA Analytic File 1995\u20132010 Custom File With County ACS Facts and Figures Projection Project. Bethesda MD: National Cancer Institute Division of Cancer Control and Population Sciences Surveillance Research Program Surveillance Systems Branch;2013."},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2007.02.004"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807023390104"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.015"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.132253599"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-475558"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198907203210302"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70070-6"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21172"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-184"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature00766"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70539-9"},{"issue":"5","key":"e_1_2_6_69_1","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jaad.2011.04.033","article-title":"Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin","volume":"65","author":"Balamurugan A","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09978.x"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70606-5"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25467"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.17.2095"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1348"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.2613"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001294"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209096"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014618"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2910"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2665"},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209978"},{"key":"e_1_2_6_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/aja.2011.102"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.0923"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.11.017"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp404"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08483.x"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1745"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20061"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12330"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.226"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/965212"},{"key":"e_1_2_6_92_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1139"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23295"},{"key":"e_1_2_6_94_1","unstructured":"National Cancer Institute.Thyroid cancer treatment (PDQ\u00ae).cancer.gov\/cancertopics\/pdq\/treatment\/thyroid\/HealthProfessional. Accessed January 23 2014."},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009233"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.09.082"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-13"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.11.010"},{"key":"e_1_2_6_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70255-9"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)51695-X"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)53725-8"},{"key":"e_1_2_6_102_1","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.221"},{"key":"e_1_2_6_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdp.2008.08.004"},{"key":"e_1_2_6_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs530"},{"key":"e_1_2_6_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmwh.2009.10.016"},{"key":"e_1_2_6_106_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-47"},{"key":"e_1_2_6_107_1","unstructured":"American College of Surgeons.Cancer program standards 2012: ensuring patient\u2010centered care. Version 1.2.1.facs.org\/cancer\/coc\/programstandards2012.pdf. Accessed April 9 2014."},{"key":"e_1_2_6_108_1","unstructured":"Alliance for Quality Psychosocial Cancer Care.A recource guide for CoC\u2010accredited facilities: meeting the Commission on Cancer patient\u2010centered standards.cfah.org\/pdfs\/Alliance_Resource_Guide_3_2014.pdf. Accessed April 9 2014."}],"container-title":["CA: A Cancer Journal for Clinicians"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.3322%2Fcaac.21235","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.3322\/caac.21235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T09:11:36Z","timestamp":1762333896000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.3322\/caac.21235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.3322\/caac.21235"],"URL":"https:\/\/doi.org\/10.3322\/caac.21235","archive":["Portico"],"relation":{},"ISSN":["0007-9235","1542-4863"],"issn-type":[{"value":"0007-9235","type":"print"},{"value":"1542-4863","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}